Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Compound amino acid injection 15AA-SF is a parenteral nutrition product developed by Guangzhou Green Cross Pharmaceutical. It is a sterile, sulfite-free (SF) formulation containing 15 essential and non-essential amino acids. The product is designed to provide nutritional support for patients who are unable to obtain adequate nutrition through oral or enteral routes, helping to maintain nitrogen balance and support protein synthesis. The 'SF' designation indicates that the formulation is free of sulfite preservatives, which is intended to reduce the risk of hypersensitivity reactions in sensitive patients. The product is currently in the NDA/BLA stage in China, with the developer conducting supplementary research as part of the regulatory approval process.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on compound amino acid injection 15AA-SF.